
NEW Capital Fund
Description
NEW Capital Fund is a Wisconsin-based private equity fund primarily focused on fostering growth among early-stage companies within the "New North" region of the state. Established in 2014, the fund successfully closed its first round of funding with $5.3 million in commitments, demonstrating a significant regional effort to address the capital needs of local startups. Operating out of Little Chute, Wisconsin, NEW Capital Fund plays a crucial role in supporting the entrepreneurial ecosystem by providing essential seed and early-stage capital that might otherwise be scarce in the area.
The fund's investment strategy is sector-agnostic within its geographic focus, yet it specifically targets promising ventures in life sciences, information technology, advanced manufacturing, and agriculture. These sectors were identified as key areas for innovation and economic growth within Northeast Wisconsin. NEW Capital Fund typically provides first cheques ranging from $100,000 to $500,000 per company, aiming to support businesses through critical development phases. This investment range is designed to help early-stage companies achieve milestones necessary for subsequent larger funding rounds or sustainable growth.
NEW Capital Fund was formed through a collaborative effort involving various regional stakeholders, including the BrightStar Wisconsin Foundation, which is dedicated to investing in Wisconsin-based companies to generate returns for charitable causes. This partnership underscores the fund's commitment not only to financial returns but also to regional economic development. By strategically deploying capital into innovative local businesses, NEW Capital Fund contributes significantly to job creation and the overall vitality of the "New North" economy, positioning itself as a vital local capital provider for emerging enterprises.
Investor Profile
NEW Capital Fund has backed more than 33 startups, with 0 new investments in the last 12 months alone. The firm has led 11 rounds, about 33% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Debt Financing rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Medical, Manufacturing.
- Typical check size: $100K – $500K.
Stage Focus
- Series Unknown (58%)
- Seed (15%)
- Debt Financing (9%)
- Angel (9%)
- Series A (6%)
- Series B (3%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Medical
- Manufacturing
- Health Care
- Software
- Life Science
- Chemical
- Pharmaceutical
- Medical Device
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.